首頁 > 市場調查報告書 > 醫療設備

整形外科

市場調查報告書

商品編碼

1138264

2022-2029 年全球肢體組織擴張器市場

Global Extremity Tissue Expanders Market - 2022-2029

出版日期: 2022年10月18日 | 出版商:

DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

全球四肢組織擴張器市場的增長受到某些因素的推動，例如技術進步、先天性畸形發病率上升以及燒傷和創傷發病率增加，這些是推動市場增長的主要驅動力之一。因素。

整形外科的興起預計將在預測期內推動全球四肢組織擴張器市場

根據美國整形外科醫師協會 (ASPS) 的最新數據，2018 年美國進行了 1590 萬例微創整容手術，其中 A 型肉毒桿菌毒素居首位。在 21 世紀初，許多先進的非手術和微創美容程序被開發出來。護理質量的提高、專業服務的改進以及高技能整容外科醫生的微創手術的可用性促成了手術數量的增加。

根據美國整形外科學會的數據，2019 年美國進行了大約 1750 萬次微創美容和外科手術。根據 2019 年國家整形外科程序統計信息交換所的數據，在北美，與 2016 年進行的手術相比，2019 年進行的乳房美容手術數量增加了 4.8%。

美國美容整形外科醫生協會 (ASAPS) 估計，2019 年美國女性接受了 256,800 次縮胸手術和大約 100,614 次隆胸手術。美國癌症協會 (ACS) 預測，2019 年美國女性中將有 278,361 例新發浸潤性乳腺癌病例，使乳房植入物成為整容手術領域的重要手術。整容手術的趨勢為四肢組織擴張器提供了積極的範圍。隨著時間的推移，重建和整容外科醫生的數量也在增加，這也將推動四肢組織擴張器市場的增長。

嚴格的監管批准阻礙了四肢組織擴張器市場的增長

但是，與採用四肢組織擴張器相關的嚴格監管批准和指南以及高昂的治療成本是在預測期內阻礙該市場增長的一些因素。

行業分析

全球四肢組織擴張器市場根據波特五力分析、供應鏈分析、監管分析、臨床試驗、定價分析和未滿足的需求等各種行業因素對市場進行了深入分析。 .

細分分析

在預測期間（2022-2029 年），乳房再造部分預計將以最快的複合年增長率增長。

預計乳房再造部分在預測期內將以最快的速度增長。乳腺癌是女性的主要癌症之一，需要進行乳房切除術以去除癌組織。根據世界衛生組織的數據，乳腺癌是女性中最常見的癌症，每年影響 210 萬女性，並導致女性癌症相關死亡人數最多。據估計，2018 年將有約 627,000 名女性死於乳腺癌，約佔所有女性癌症死亡人數的 15%。發達地區女性的乳腺癌發病率很高，但世界上幾乎每個地區的發病率都在上升。 Extremity Tissue Expander 是為乳腺癌手術填充乳房植入物的基本模型。因此，乳腺癌患病率的上升是導致乳房重建部分增長的主要因素之一。

全球四肢組織擴張器市場報告提供大約 40 多個市場數據表、45 多個圖表和 180 頁內容

Extremity Tissue Expanders Market is expected to grow at a high CAGR of 6% during the forecasting period (2022 - 2029). Tissue expansion is a process used by reconstructive surgeons to help the body grow new skin, bone, or other tissues. It is commonly used in adults and children for skin reconstruction. Extremity Tissue expanders are applicable for a variety of reconstructive problems, ranging from the treatment of congenital defects to the secondary reconstruction of extensive burn scars.

Tissue expanders have a similar function as a balloon. Initially, tissue expanders are relatively flat and filled with saline or air saline through a valve. This process puts pressure and promotes the growth of new tissue. These are mainly used for soft tissue expansion in cases of soft tissue and skin tumor. The outer layer of the expander is made up of silicone, and it is filled with saline water or silicone depending upon the requirement of the procedure. Mostly, tissue expanders are round or rectangular shaped, with 50 ccs to 1000 cc volume capability. Differential expanders and anatomical expanders are the two types of expanders used primarily to repair specific defects.

The Extremity Tissue Expanders Market study analysis offers an in-depth outlook on the market containing both quantitative, and qualitative data. It gives an outlook and forecast of the global market based on the Extremity Tissue Expanders Market segmentation by product type, product shape, application and end user. It also provides Extremity Tissue Expanders Market size, and growth, along with the latest trends, opportunities, and forecast till 2029 for the global market with esteem to major countries such as the United States, Canada, Brazil, Germany, Italy, Spain, United Kingdom, Russia, European countries, United Arab Emirates, Saudi Arabia, South Africa, Japan, China, India, South Korea, Australia, and rest of the countries over the globe.

Market Dynamics

The global extremity tissue expanders market growth driven by certain factors such as technological advancements, rising incidence of congenital deformity, and the increasing number of burn and traumatic injuries are among the key factors driving the market growth.

An increasing number of plastic surgeries is expected to drive the global extremity tissue expanders market during the forecast period

According to the recent data of the American Society of Plastic Surgeons (ASPS), in 2018 among the 15.9 million cosmetic minimally-invasive procedures performed in the United States, Botulinum Toxin Type A tops the list with 7.44 million procedures. Many advanced non-surgical and minimally invasive aesthetic procedures were developed at the beginning of the 21st century. The increasing quality of care improved professional services, and the availability of minimally invasive surgeries by highly qualified aesthetic surgeons have contributed to the growth of procedural volume.

According to the American Society of Plastic Surgery, there were about 17.5 million minimally invasive cosmetic and surgical procedures performed in the U.S. in 2019. In North America, as per the National Clearinghouse of Plastic Surgery Procedural Statistics 2019, aesthetic breast surgeries witnessed an increase of 4.8% in the number of surgeries performed in 2019 as compared to the surgical procedures performed in 2016.

The American Society of Aesthetic Plastic Surgery (ASAPS) estimated 256,800 breast reduction surgeries and around 100,614 breast lift surgeries among U.S. women in the year 2019. The American Cancer Society (ACS), projected that 278,361 new cases of invasive breast cancer were diagnosed among women in 2019 in the U.S. Breast implantation is considered a significant procedure in the field of cosmetic surgery. The trend towards cosmetic surgeries provides a positive scope for extremity tissue expanders. The number of practice surgeons in reconstructive and cosmetic surgeries is also rising with time which will also boost the growth of the extremity tissue expanders market.

Stringent regulatory approvals hampering the growth of the extremity tissue expanders market

However, stringent regulatory approvals and guidelines related to the adoption of the extremity tissue expander, along with high treatment costs are some of the factors hampering the growth of this market during the forecast period.

Industry Analysis

The global extremity tissue expanders market provides in-depth analysis of the market based on various industry factors such as porter's five force analysis, supply chain analysis, regulatory analysis, clinical trials, pricing analysis, unmet needs.

Segmentation Analysis

The breast reconstruction segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The breast reconstruction segment is expected to grow at the fastest growth rate over the forecast period. Breast Cancer is one of the major types of cancer in women, which requires mastectomy for the removal of cancerous tissues. According to the WHO, breast cancer is the most frequent cancer among women, impacting 2.1 million women annually, and also causes the greatest number of cancer-related deaths among women. In 2018, it was estimated that about 627,000 women died from breast cancer, i.e. around 15% of all cancer deaths among women. While breast cancer rates are higher among women in more developed regions, rates are increasing in nearly every region globally. Extremity Tissue expanders are the basic model to fill the breast implant for the growing number of surgeries for breast cancer. Hence, the rising prevalence of breast cancer prevalence is one of the major factors contributing to the growth of the breast reconstruction segment.

Geographical Analysis

North America region holds the largest market share of the global extremity tissue expanders market

The North American region is dominating the global extremity tissue expanders market accounted for the largest market share in 2019, owing to the rising prevalence of sports-related injuries, accidental causes, and burn cases. As per the U.S. Department of Health and Human Services, around two million people in the U.S. suffer from sports injuries annually.

In this region, the U.S. dominated the market in terms of revenue due to the presence of advanced healthcare infrastructure, increasing healthcare spending, and the widespread prevalence of various congenital disorders. As per the Centers for Disease Control and Prevention (CDC), 1 in every 33 babies born in the U.S. is affected by a birth defect. Besides, the rise in the number of reconstructive surgeries in the country has led to high demand for these products.

In North America, as per the 2019 statistics of International Society for Aesthetic Plastic Surgeons (ISAPS), there were about 1,795,551 breast augmentation procedures all over the world in 2019 which was more than any other performed aesthetic surgery. According to the 2020 report of the American Society of Plastic Surgeons, breast augmentation was one of the top five cosmetic surgical procedures performed in 2020 in the United States, the total number was 193,073 breast augmentation procedures in 2020. The increasing prevalence of breast cancer in North America will also complement the growth of the breast implant market in the region. As per the GLOBOCAN 2020 report, the new breast cancer cases in the United States, Canada, and Mexico were 253,465: 28,026; and 29,929, respectively in 2020.

In Canada, the market is projected to grow at a significant growth rate during the forecast period, owing to a rise in the number of road accidents and trauma injuries which increases the demand for these expanders in leg and arm reconstruction procedures.

Competitive Landscape

The global extremity tissue expanders market is moderately competitive with few major players and small players. Some of the key players which are contributing to the growth of the market include Allergan PLC, Mentor Worldwide LLC, Eurosurgical Ltd., GC Aesthetics PLC, Eurosilicone S.A.S., Laboratories Arion, Groupe Sebbin SAS, Guangzhou Wanhe Plastic Materials Co. Ltd., Koken Co. Ltd, Sientra, Inc., Koken Co. Ltd., among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the extremity tissue expanders market globally. For instance,

In June 2020, Allergan Aesthetics, an AbbVie company has initiated a new digital campaign to improve device tracking and further identify and reach breast implant patients who have, or have had, BIO CELL breast implants and/or tissue expanders to inform them of the risk of BIA-ALCL. Since July 2019 when the BIO CELL recall was announced, robust efforts were made to reach patients, however, the Company is still seeking to directly contact all U.S. BIO CELL patients that have not yet been notified. This is due to incomplete device tracking data for approximately 52,000 BIO CELL breast implant units.

In November 2016, Sientra, Inc., a medical aesthetics company, has acquired the complete portfolio of premium, differentiated tissue expanders from industry pioneer Specialty Surgical Products, Inc. (SSP). With this acquisition, Sientra adds to its product offering the AlloX2 and Dermaspan lines of breast tissue expanders, in addition to the Softspan line of extremity expanders. In 2019, Illumina acquired Pacific Biosciences, one of the leading providers of sequencing systems. This helped Illumina strengthen its sequencing product portfolio.

Global Extremity Tissue Expanders Market - Key Companies to Watch

Allergan Plc

Overview: Allergan Plc is a bold, global pharmaceutical company. It is focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world.

Product Portfolio: NATRELLE 133 Tissue Expanders- are designed as part of a system for breast reconstruction to create a pocket for placement of a NATRELLE breast implant.

The global extremity tissue expanders market report would provide an access to an approx. 40+ market data table, 45+ figures and 180 pages

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

3.1. Market Snippet by Product Type
3.2. Market snippet by Product Shape
3.3. Market snippet by Application
3.4. Market Snippet by End-User
3.5. Market Snippet by Region

4. Market Dynamics

4.1. Market Impacting Factors
4.2. Drivers
- 4.2.1. Technological advancements
- 4.2.2. Rising incidence of congenital deformity
- 4.2.3. The increasing number of burn and traumatic injuries
- 4.2.4. XX
4.3. Restraints:
- 4.3.1. Availability of other reconstructive surgeries
- 4.3.2. XX
4.4. Opportunity
4.5. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. COVID-19 Impact Analysis

6. By Product Type

6.1. Introduction
6.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type Segment
6.3. Market Attractiveness Index, By Product Type Segment
- 6.3.1. Lower Extremity*
  - 6.3.1.1. Introduction
  - 6.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
- 6.3.2. Upper Extremity

7. By Product Shape

7.1. Introduction
7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Shape
7.3. Market Attractiveness Index, By Product Shape Segment
- 7.3.1. Rectangular*
  - 7.3.1.1. Introduction
  - 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
- 7.3.2. Crescent
- 7.3.3. Anatomical
- 7.3.4. Round
- 7.3.5. Others

8. By Application

8.1. Introduction
8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
8.3. Market Attractiveness Index, By Application Segment
- 8.3.1. Scalp reconstruction*
  - 8.3.1.1. Introduction
  - 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
- 8.3.2. Breast reconstruction
- 8.3.3. Oral and maxillofacial reconstruction
- 8.3.4. Pediatrics
- 8.3.5. Others

9. By End-User

9.1. Introduction
9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User Segment
9.3. Market Attractiveness Index, By End-User Segment
- 9.3.1. Hospitals*
  - 9.3.1.1. Introduction
  - 9.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
- 9.3.2. Cosmetic Clinics
- 9.3.3. Ambulatory Care Centers
- 9.3.4. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
- 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Shape
- 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
- 10.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. The U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
- 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Shape
- 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
- 10.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. The U.K.
  - 10.3.7.3. France
  - 10.3.7.4. Italy
  - 10.3.7.5. Spain
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
- 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Shape
- 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
- 10.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Brazil
  - 10.4.7.2. Argentina
  - 10.4.7.3. Rest of South America
10.5. Asia Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
- 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Shape
- 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
- 10.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 10.5.7.1. China
  - 10.5.7.2. India
  - 10.5.7.3. Japan
  - 10.5.7.4. Australia
  - 10.5.7.5. Rest of Asia Pacific
10.6. The Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
- 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Shape
- 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Allergan PLC*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Key Highlights
- 12.1.4. Financial Overview
12.2. Mentor Worldwide LLC
12.3. Eurosurgical Ltd.
12.4. GC Aesthetics PLC
12.5. Eurosilicone S.A.S.
12.6. Laboratories Arion.
12.7. Groupe Sebbin SAS
12.8. Guangzhou Wanhe Plastic Materials Co. Ltd. Koken Co. Ltd
12.9. Sientra, Inc.
12.10. Koken Co. Ltd. (List Not Exhaustive)